litlas
Log inCreate account

Olivier Lambotte

Active 2000–2025

167
Papers
28,884
Citations
82
h-index
159
i10-index

Citations

Citations per year for Olivier Lambotte2001: 4 citations2002: 8 citations2003: 6 citations2004: 5 citations2005: 8 citations2006: 15 citations2007: 62 citations2008: 87 citations2009: 129 citations2010: 169 citations2011: 174 citations2012: 176 citations2013: 198 citations2014: 195 citations2015: 172 citations2016: 197 citations2017: 259 citations2018: 309 citations2019: 1,078 citations2020: 1,337 citations2021: 1,444 citations2022: 1,135 citations2023: 749 citations2024: 1,244 citations2025: 497 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,357 citing papers, 26.1% of this breakdownChina: 1,205 citing papers, 9.4% of this breakdownFrance: 950 citing papers, 7.4% of this breakdownUnited Kingdom: 727 citing papers, 5.6% of this breakdownItaly: 717 citing papers, 5.6% of this breakdownGermany: 525 citing papers, 4.1% of this breakdownCanada: 477 citing papers, 3.7% of this breakdownSpain: 443 citing papers, 3.4% of this breakdownAustralia: 362 citing papers, 2.8% of this breakdownJapan: 357 citing papers, 2.8% of this breakdownNetherlands: 307 citing papers, 2.4% of this breakdownSwitzerland: 270 citing papers, 2.1% of this breakdown
0%26.1%Other 24.6%

Institutions

Fields

  • Medicine63%
  • Immunology and Microbiology26.3%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Engineering1.2%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other1.1%

Topics

  • Cancer Immunotherapy and Biomarkers10%
  • HIV Research and Treatment7.5%
  • Immune Cell Function and Interaction6.2%
  • HIV/AIDS Research and Interventions2.9%
  • Immunotherapy and Immune Responses2.6%
  • CAR-T cell therapy research2.6%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Immune-related adverse events of checkpoint inhibitors

    Authors: Manuel Ramos‐Casals, Julie R. Brahmer, Margaret K. Callahan, Alejandra Flores-Chávez, Niamh M. Keegan, Munther A. Khamashta, Olivier Lambotte, Xavier Mariette, Aleix Prat, María E. Suarez‐Almazor - Nature Reviews Disease Primers 2020 cited by 1,388

  2. Immune-related adverse events with immune checkpoint blockade: a comprehensive review

    Authors: Jean‐Marie Michot, Camille Bigenwald, Stéphane Champiat, Michael Collins, Franck Carbonnel, Sophie Postel‐Vinay, A. Berdelou, Andreea Varga, Rastislav Bahleda, Antoine Hollebecque, Christophe Massard, Alina Fuerea, Vincent Ribrag, Anas Gazzah, Jean‐Pierre Armand, Nadia Amellal, Eric Angevin, Nicolas Noël, C. Boutros, Christine Mateus, Caroline Robert, Jean‐Charles Soria, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2016 cited by 2,129

  3. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

    Authors: C. Boutros, Ahmad A. Tarhini, Émilie Routier, Olivier Lambotte, François Leroy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurélien Marabelle, Stéphane Champiat, Armandine Berdelou, Émilie Lanoy, Matthieu Texier, C. Libenciuc, Alexander M.M. Eggermont, Jean‐Charles Soria, Christine Mateus, Caroline Robert - Nature Reviews Clinical Oncology 2016 cited by 1,100

  4. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome

    Authors: L. Fardet, Lionel Galicier, Olivier Lambotte, Christophe Marzac, Cédric Aumont, D. Chahwan, Paul Coppo, Gilles Hejblum - Arthritis & Rheumatology 2014 cited by 1,422

  5. Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Authors: Jason M. Brenchley, David A. Price, Timothy W. Schacker, Tedi E. Asher, Guido Silvestri, Srinivas S. Rao, Zachary Kazzaz, Ethan Bornstein, Olivier Lambotte, Daniel M. Altmann, Bruce R. Blazar, Benigno Rodríguez, Leia Teixeira-Johnson, Alan Landay, Jeffrey N. Martin, Frederick Hecht, Louis J. Picker, Michael M. Lederman, Steven G. Deeks, Daniel C. Douek - Nature Medicine 2006 cited by 3,542

  6. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

    Authors: Steven G. Deeks, Nancie M. Archin, Paula M. Cannon, Simon Collins, R. Brad Jones, Marein A.W.P. de Jong, Olivier Lambotte, Rosanne Lamplough, Thumbi Ndung’u, Jeremy Sugarman, Caroline T. Tiemessen, Linos Vandekerckhove, Sharon R. Lewin, The International AIDS Society (IAS) Global Scientific Strategy working group, Core Leadership Group, Steven G. Deeks, Sharon R. Lewin, Marein de Jong, Working Group 1 (Understanding HIV reservoirs), Zaza M. Ndhlovu, Nicolas Chomont, Zabrina L. Brumme, Kai Deng, Luke D. Jasenosky, Richard Jefferys, Aurelio Orta‐Resendiz, Working Group 2 (HIV reservoir measurement), Frank Mardarelli, Monique Nijhuis, Katharine J. Bar, Bonnie J. Howell, Alex Schneider, Gabriela Turk, Rose Nabatanzi, Working Group 3 (Mechanisms of virus control), Joel N. Blankson, J. Víctor García, Mirko Paiardini, Jan van Lunzen, Christina Antoniadi, Fernanda Heloise Côrtes, Working Group 4 (Targeting the provirus), Susana Valente, Ole S. Søgaard, Ricardo Sobhie Diaz, Melannie Ott, Richard M. Dunham, Siegfried Schwarze, Santiago Perez Patrigeon, Josephine Nabukenya, Working Group 5 (Targeting the immune system), Marina Caskey, Beatriz Mothe, Fu Sheng Wang, Sarah Fidler, Devi SenGupta, Stephan Dressler, Mitch Matoga, Working Group 6 (Cell and gene therapy), Hans‐Peter Kiem, Pablo Tebas, Cissy Kityo, Boro Dropulić, Michael Louella, Kumitaa Theva Das, Working Group 7 (Paediatric remission and cure), Deborah Persaud, Ann Chahroudi, Katherine Luzuriaga, Thanyawee Puthanakit, Jeffrey T. Safrit, Gaerolwe Masheto, Working Group 8: (Social, behavioral and ethical aspects of cure), Karine Dubé, Jennifer Power, Jessica Salzwedel, Udom Likhitwonnawut, Jeff Taylor, Oguzhan Latif Nuh, Krista L. Dong, Edward Nelson Kankaka - Nature Medicine 2021 cited by 368

  7. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

    Authors: Eléonora De Martin, Jean‐Marie Michot, Barbara Papouin, Stéphane Champiat, Christine Mateus, Olivier Lambotte, Bruno Roche, Térésa Antonini, Audrey Coilly, Salim Laghouati, Caroline Robert, Aurélien Marabelle, Catherine Guettier, Didier Samuel - Journal of Hepatology 2018 cited by 532

  8. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

    Authors: Asier Sáez‐Cirión, Charline Bacchus, Laurent Hocqueloux, Véronique Avettand-Fènoël, Isabelle Girault, Camille Lécuroux, Valérie Potard, Pierre Versmisse, Adeline Mélard, Thiérry Prazuck, Benjamin Descours, Julien Guergnon, Jean‐Paul Viard, Faroudy Boufassa, Olivier Lambotte, Cécile Goujard, Laurence Meyer, Dominique Costagliola, Alain Venet, Gianfranco Pancino, Brigitte Autran, Christine Rouzioux, the ANRS VISCONTI Study Group - PLoS Pathogens 2013 cited by 998

  9. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

    Authors: Stéphane Champiat, Olivier Lambotte, Emmanuel Barreau, Rakiba Belkhir, A. Berdelou, Franck Carbonnel, Cécile Cauquil, P. Chanson, Michael Collins, Antoine Dürrbach, Stéphane Éderhy, S. Feuillet, Arnaud François, Julien Lazarovici, Jérôme Le Pavec, Eléonora De Martin, Christine Mateus, Jean‐Marie Michot, Didier Samuel, Jean‐Charles Soria, Caroline Robert, Alexander M.M. Eggermont, Aurélien Marabelle - Annals of Oncology 2015 cited by 893

  10. Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer

    Authors: Audrey Simonaggio, Jean‐Marie Michot, Anne Laure Voisin, Jérôme Le Pavec, Michael Collins, A. Lallart, Geoffray Cengizalp, Aurore Vozy, Ariane Laparra, Andréa Varga, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Christophe Massard, Olivier Lambotte - JAMA Oncology 2019 cited by 372

  11. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

    Authors: Alice Tison, Gilles Quéré, L. Misery, Elisa Funck‐Brentano, François‐Xavier Danlos, Émilie Routier, Caroline Robert, Yohann Loriot, Olivier Lambotte, B. Bonniaud, C. Scalbert, Sarah Maanaoui, Thierry Lesimple, Stéphanie Martinez, M. Marcq, C. Chouaïd, Cathérine Dubos, F. Brunet‐Possenti, C. Stavris, Laurent Chiche, N. Bénéton, Sandrine Mansard, Florian Guisier, H. Doubre, F. Skowron, F. Aubin, O. Zehou, C. Rogé, Mickaël Lambert, Anne Pham‐Ledard, M. Beylot‐Barry, Rémi Veillon, N. Kramkimel, Damien Giacchero, Julie De Quatrebarbes, Catherine Michel, J.B. Auliac, Gilles Gonzales, C. Decroisette, G. Le Garff, Ioana Carpiuc, H. Vallerand, Emmanuel Nowak, Divi Cornec, Marie Kostine, Groupe de Cancérologie Cutanée, Groupe Français de Pneumo‐Cancérologie, and Club Rhumatismes et Inflammations - Arthritis & Rheumatology 2019 cited by 312

  12. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

    Authors: Marie Kostine, Axel Finckh, Clifton O. Bingham, Karen Visser, Jan Leipe, Hendrik Schulze‐Koops, Ernest Choy, Karolina Benesova, Timothy R. D. J. Radstake, Andrew P. Cope, Olivier Lambotte, Jacques‐Eric Gottenberg, Yves Allenbach, Marianne E Visser, Cindy Rusthoven, Lone Thomasen, Shahin Jamal, Aurélien Marabelle, James Larkin, John B.A.G. Haanen, Leonard H. Calabrese, Xavier Mariette, Thierry Schaeverbeke - Annals of the Rheumatic Diseases 2020 cited by 276

  13. Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

    Authors: François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean‐Marie Michot, Émilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albigès, Christophe Massard, Nicolas Girard, Stéphane Dalle, Benjamin Besse, Salim Laghouati, Jean‐Charles Soria, Christine Mateus, Caroline Robert, Émilie Lanoy, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2018 cited by 311

  14. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

    Authors: Jean‐Marie Michot, Julien Lazarovici, Ashley Tieu, Stéphane Champiat, Anne-Laure Voisin, Mikaël Ebbo, Bertrand Godeau, Marc Michel, Vincent Ribrag, Olivier Lambotte - European Journal of Cancer 2019 cited by 173

  15. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

    Authors: Valentine Ruste, Vincent Goldschmidt, Ariane Laparra, Sabine Messayke, François‐Xavier Danlos, Patricia Romano‐Martin, Stéphane Champiat, Anne-Laure Voisin, Capucine Baldini, Christophe Massard, Salim Laghouati, Aurélien Marabelle, Olivier Lambotte, Jean‐Marie Michot - European Journal of Cancer 2021 cited by 83

  16. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

    Authors: Yves Allenbach, C. Anquetil, Ali Manouchehri, Olivier Benvéniste, Olivier Lambotte, Bénédicte Lebrun‐Vignes, Jean‐Philippe Spano, Stéphane Éderhy, David Klatzmann, Michèlle Rosenzwajg, Bruno Fautrel, Jacquès Cadranel, Douglas B. Johnson, Javid J. Moslehi, Joe‐Elie Salem - Autoimmunity Reviews 2020 cited by 141

  17. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

    Authors: Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont, N. Kramkimel, Julien Lazarovici, Romain Dupont, Stéphane Champiat, Claude Chahine, Caroline Robert, Charles Herbaux, Benjamin Besse, Aude Guillemin, Christine Mateus, Patricia Pautier, Philippe Saïag, Emanuela Madonna, Marie Maerevoet, Jean-Christophe Bout, Charlotte Leduc, P. Biscay, Gilles Quéré, Charlée Nardin, Mikaël Ebbo, Laurence Albigès, Grégoire Marret, Virginie Levrat, C. Dujon, Jacques Vargaftig, Salim Laghouati, Laure Croisille, Anne-Laure Voisin, Bertrand Godeau, Christophe Massard, Vincent Ribrag, Aurélien Marabelle, Marc Michel, Olivier Lambotte - The Lancet Haematology 2018 cited by 292

  18. Elimination of HIV-1-infected cells by broadly neutralizing antibodies

    Authors: Timothée Bruel, Florence Guivel‐Benhassine, Sonia Amraoui, Marine Malbec, Léa Richard, Katia Bourdic, Daniel A. Donahue, Valérie Lorin, Nicoletta Casartelli, Nicolas Noël, Olivier Lambotte, Hugo Mouquet, Olivier Schwartz - Nature Communications 2016 cited by 266

  19. Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

    Authors: Layal Rached, Ariane Laparra, Madona Sakkal, François‐Xavier Danlos, Fabrice Barlési, Franck Carbonnel, Eléonora De Martin, Michel Ducreux, C. Even, Jérôme Le Pavec, Jean‐Marie Michot, Joana M. Ribeiro, Florian Scotté, Santiago Ponce Aix, Olivier Lambotte, Capucine Baldini, Stéphane Champiat - Cancer Treatment Reviews 2024 cited by 86

  20. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

    Authors: Asier Sáez‐Cirión, Christine Lacabaratz, Olivier Lambotte, Pierre Versmisse, Alejandra Urrutia, Faroudy Boufassa, Françoise Barré‐Sinoussi, Jean‐François Delfraissy, Martine Sinet, Gianfranco Pancino, Alain Venet - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 622

  21. Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

    Authors: Capucine Baldini, P. Martin Romano, Anne-Laure Voisin, François‐Xavier Danlos, Stéphane Champiat, Salim Laghouati, Maria Kfoury, H. Vincent, Sophie Postel‐Vinay, Andreea Varga, Perrine Vuagnat, Vincent Ribrag, Laura Mezquita, Benjamin Besse, Antoine Hollebecque, Olivier Lambotte, Jean‐Marie Michot, Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle - European Journal of Cancer 2020 cited by 84

  22. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells

    Authors: Matthieu Mahévas, Pauline Patin, François Huetz, Marc Descatoire, Nicolas Cagnard, Christine Bôle‐Feysot, Simon Le Gallou, Mehdi Khellaf, Olivier Fain, David Boutboul, Lionel Galicier, Mikaël Ebbo, Olivier Lambotte, M. Hamidou, Philippe Bierling, Bertrand Godeau, Marc Michel, Jean–Claude Weill, Claude–Agnès Reynaud - Journal of Clinical Investigation 2012 cited by 194

  23. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

    Authors: Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux, Matthieu Resche‐Rigon, Raphaël Porcher, Philippe Ravaud, CORIMUNO-19 Collaborative Group, Serge Bureau, Maxime Dougados, Annick Tibi, Élie Azoulay, Jacques Cadranel, Joseph Emmerich, Muriel Fartoukh, Bertrand Guidet, Marc Humbert, Karine Lacombe, Matthieu Mahévas, Frédéric Pène, Valérie Pourchet-Martinez, F. Schlemmer, Yazdan Yazdanpanah, Gabriel Baron, Élodie Perrodeau, Damien Vanhoye, Cécile Kedzia, Lauren Demerville, Anne Gysembergh-Houal, Alexandre Bourgoin, Sarah Dalibey, Matthieu Resche‐Rigon, Nabil Raked, Lakhdar Mameri, Stéphanie Alary, Samir Hamiria, Thinhinane Bariz, Hala Semri, Dhiaa Meriem Hai, Moustafa Benafla, Mohamed Belloul, Pernelle Vauboin, Saskia Flamand, Claire Pacheco, Anouk Walter‐Petrich, E. Ya. Stan, Souad Benarab, Corine Nyanou, Claire Montlahuc, Lucie Biard, Robin Charreteur, Celine Dupré, Kévin Cardet, Blandine Lehmann, Kamyl Baghli, Claire Madeleine, Éric D’Ortenzio, Oriane Puéchal, Caroline Semaille, Laurent Savale, Anatole Harrois, Samy Figueiredo, Jacques Duranteau, Nadia Anguel, Xavier Monnet, Christian Richard, Jean–Louis Teboul, Philippe Durand, Pierre Tissières, Mitja Jevnikar, David Montani, Stéphan Pavy, Nicolas Noël, Olivier Lambotte, L. Escaut, Stéphane Jauréguiberry, Élodie Baudry, Christiane Verny, Édouard Lefèvre, Mohamad Zaidan, Clotilde Le Tiec, Céline Verstuyft, Anne-Marie Roques, Lamiae Grimaldi‐Bensouda, Domitille Molinari, Gaël Leprun, Alain Fourreau, Laurent Cylly, Myriam Virlouvet, Ramdane Meftali, Solène Fabre, Marion Licois, Asmaa Mamoune, Yacine Boudali, Sophie Georgin‐Lavialle, Patricia Senet, A. Soria, Antoine Parrot, H. François, N. Rozensztajn, Emmanuelle Blin and 494 more - JAMA Internal Medicine 2020 cited by 777

  24. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

    Authors: S. Le Burel, Stéphane Champiat, Christine Mateus, Aurélien Marabelle, Jean‐Marie Michot, Caroline Robert, Rakiba Belkhir, Jean‐Charles Soria, Salim Laghouati, Anne-Laure Voisin, O. Fain, A. Mékinian, Laetitia Coutte, Tali‐Anne Szwebel, Laetitia Dunogeant, Bertrand Lioger, Cécile Luxembourger, Xavier Mariette, Olivier Lambotte - European Journal of Cancer 2017 cited by 199